Track the 안지오랩 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 안지오랩 has recorded 29 public disclosures. The latest transaction was filed on 22 January 2026 (Sale). Among the most active insiders: 인터베스트. All data is openly available.
24
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
13 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
안지오랩 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de tratamientos innovadores para enfermedades cardiovasculares.